Bio-Rad Laboratories has signed an agreement to acquire certain diagnostic businesses of Biotest for 45 million euros, the terms of which were not disclosed. The transaction is subject to closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2010.
Biotest develops, manufactures and markets pharmaceutical, biotherapeutic and diagnostic products. Integrating Biotest’s diagnostic business into Bio-Rad’s product portfolio will broaden the company’s offering in the area of immunohematology and provide Bio-Rad access to the US markets with a full range of products.
Phone: 0011 1 510 724 7000
Waters BD FACSDiscover A7 Cell Analyzer
The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...
Lumiprobe CytoTracer fluorescent cell dyes
The dyes rapidly penetrate cells, form intracellular membrane-impermeable products, and deliver...
Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit
The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...
